UNSPSC 51273828: Methacholine/methyl salicylate

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class DE650. This VA Drug Class (DE650) classifies this compound as belonging to the group ANALGESICS, TOPICAL.

UNSPSC 51273828 Methacholine/methyl salicylate is a Commodity code that shows limited direct activity but sits within state and local pharmaceutical procurement spanning naloxone, injectable medications, and over-the-counter products distributed through authorized wholesalers and direct-to-provider supply chains. State and local procurement under related pharmaceutical codes involves county health departments, state health and human services commissions, and multistate cooperative purchasing alliances seeking drugs and medical products for community health initiatives, emergency response programs, and institutional healthcare delivery. The work includes competitive bidding for branded and generic pharmaceuticals, management of multi-source products through authorized wholesalers with chargeback systems, compliance with FDA and Drug Supply Chain Security Act (DSCSA) requirements, and submission of detailed product specifications including National Drug Codes, SKUs, and pricing models.

Recent activity spans Florida, Texas, and Minnesota. Seminole County, Florida issued IFB 60459723LAS in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries and a response deadline of July 26, 2023. The Texas Health and Human Services Commission posted RFI HHS0017013 on April 3, 2026 to gather vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program linking state pharmacy benefit management to pharmaceutical manufacturers outside traditional pharmacy benefit manager and group purchasing organization channels. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued RFP S1070000015802 in January 2026 establishing multiple contracts for generic multi-source pharmaceuticals and over-the-counter products distributed through AmerisourceBergen, Cardinal Health, and Morris & Dickson, with proposals due March 26, 2026 and contract awards effective July 1, 2026. Vendors must maintain insurance coverage including $5 million commercial general liability per occurrence and comply with 3 percent administrative fees on contract purchases.